Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,505	13,820	12,946	11,482	8,080	8,955
Market Cap Growth	30.20%	6.75%	12.75%	42.11%	-9.78%	-9.54%
Enterprise Value	14,870	12,878	12,124	10,966	7,766	8,528
Last Close Price	155.51	136.50	131.76	119.44	85.17	95.85
PE Ratio	37.10	40.49	51.85	74.32	90.18	21.99
Forward PE	17.39	18.15	21.34	22.53	24.55	22.30
PS Ratio	5.76	5.87	6.86	7.71	7.13	8.56
PB Ratio	5.16	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	5.22	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	26.14	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	24.35	23.21	33.20	33.83	31.50	39.19
PEG Ratio	1.14	0.31	0.65	0.66	0.37	0.37
EV/Sales Ratio	5.54	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	26.09	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	27.52	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	25.07	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.16	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.81	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.69	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	17.15	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.89	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.38	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.96%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.66%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	10.41%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	2.76%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	3.83%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	1.30%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q